Thorac Cardiovasc Surg 2021; 69(S 01): S1-S85
DOI: 10.1055/s-0041-1725601
Oral Presentations
Saturday, February 27
Basic Science - Kardiovaskuläre Medizin

The Sodium-Glucose Cotransporter-2 Inhibitor Canagliflozin Alleviates Endothelial Dysfunction of Vascular Grafts Submitted to In-Vitro Ischemia/Reperfusion Injury in Nondiabetic Rats

S. Korkmaz-Icöz
1   Heidelberg, Deutschland
,
C. Kocer
1   Heidelberg, Deutschland
,
A. A. Sayour
1   Heidelberg, Deutschland
,
M. I. Benker
1   Heidelberg, Deutschland
,
S. Abulizi
1   Heidelberg, Deutschland
,
S. Loganathan
1   Heidelberg, Deutschland
,
P. Brlecic
1   Heidelberg, Deutschland
,
M. Ruppert
1   Heidelberg, Deutschland
,
T. Radovits
2   Budapest, Hungary
,
M. Karck
1   Heidelberg, Deutschland
,
G. Szabó
1   Heidelberg, Deutschland
› Author Affiliations
 

    Objectives: Ischemia/reperfusion (IR) injury is a challenge during coronary artery bypass surgery. It can induce vascular graft injury. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, used for treating patients with type 2 diabetes, have been shown to protect against myocardial IR injury in experimental models, irrespective of diabetes. We hypothesized that physiological saline-supplemented canagliflozin (CANA), a SGLT2 inhibitor, protects vascular grafts from IR injury in rats.

    Methods: Thoracic aortic rings from non-diabetic male Wistar rats were explanted, prepared, and immediately mounted in organ bath chambers (control group, n = 39 rings from 10 rats) or underwent 24 hours of cold ischemic preservation in saline, supplemented either with 0.5% DMSO vehicle (IR group, n = 40 rings from 10 rats) or 50 µM CANA (IR + CANA group, n = 42 rings from 11 rats). Reperfusion-induced endothelial injury was simulated by hypochlorite. Relaxation of phenylephrine precontracted aortic rings was investigated by acetylcholine (ACh), an endothelium-dependent vasorelaxant and by sodium nitroprusside (SNP), an endothelium-independent vasodilator. Additionally, we analyzed the expression of 88 genes using polymerase chain reaction (PCR) array.

    Result: Impaired maximal vasorelaxation (Rmax) to ACh in the IR group compared with controls was significantly ameliorated by CANA, indicating an improvement in endothelial function (Rmax to ACh (%) control 75.2 ± 2.3 vs. IR 31.7 ± 3.2 vs. IR + CANA 51.9 ± 2.5, p < 0.05). Additionally, decreased aortic ring sensitivity (pD2-value: -log 50% maximum response) to ACh seen after IR in the vehicle group was increased by CANA (pD2 to ACh control 7.4 ± 0.1 vs. IR 6.3 ± 0.2 vs. IR + CANA 6.9 ± 0.1, p < 0.05). Although there was no difference in Rmax to SNP, the concentration–response curve in aortas from the IR + CANA group was left-shifted compared with the IR group (pD2 to SNP: control 8.7 ± 0.1 vs. IR 8.0 ± 0.1 vs. IR + CANA 8.5 ± 0.1, p < 0.05). According to the PCR array analysis, IR altered the expression of 17 genes. Compared with controls, IR upregulated the mRNA expressions of IL1a and IL6, which were reduced by 1.5- and 1.75-fold with CANA, respectively. Furthermore, CANA prevented the upregulation of Cd40 and significantly downregulated NoxO1 gene expression.

    Conclusion: Preservation of vascular grafts with CANA protects from endothelial dysfunction following IR injury. Its protective effects may be due to downregulation of proinflammatory genes and genes related to vascular injury.


    #

    No conflict of interest has been declared by the author(s).

    Publication History

    Article published online:
    19 February 2021

    © 2021. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany